Biotech firms VALANX Biotech and Fina Biosolutions have announced a collaborative agreement to commercialise ClickCRM, an engineered version of the carrier protein CRM197 designed to accelerate conjugate vaccine development. The partnership, announced on 29 October 2024, combines VALANX’s expertise in site-specific protein conjugation with FinaBio’s established presence in conjugate vaccine development.

Takara Bio Europe has expanded its Gothenburg facility with a new custom manufacturing laboratory, significantly boosting its capacity to produce molecular biology reagents for the EMEA region. The facility, which became operational on 1 October 2024, is capable of manufacturing up to 600,000 reactions weekly, addressing the growing demands of academic research institutions, diagnostic laboratories, […]

SGS, the global testing and certification organisation, has unveiled a specialised consultancy service focused on transforming the complex process of clinical trial data submissions. The CDISC Open Rules Consultancy aims to address the increasingly intricate requirements of regulatory compliance in clinical research.

A novel integration of protein footprinting and ion mobility mass spectrometry technologies promises to accelerate structural biology research in the biopharmaceutical sector, following a collaboration announced by GenNext Technologies and Agilent.